2011

Euskirchen P, Skaftnesmo KO, Huszthy PC, Brekkå N, Bjerkvig R, Jacobs AH, Miletic H. NUMB does not impair growth and differentiation status of experimental gliomas. Exp Cell Res 317(20):286473, 2011.

Evensen, L., Link, W., Lorens, J.B. High throughput microscopy in angiogenesis and drug discovery. In High Throughput Microscopy (D. Taatjes, J. Roth, Eds.) (Methods in Molecular Biology Series, John M. Walker, Series Editor; Human Press, Springer Science. Submitted, August 2011.

Napolitano, C., Natoni, A., Santocanale, C., Evensen, L., Lorens, J.B. and Murphy, P.V. Isosteric replacement of the Z-enone with haloethyl ketone and E-enone in a resorcylic acid lactone series and biological evaluation. Bioorg.Med.Chem Lett 21(4):1167-70, 2011.

Wang J, Daphu I, Pedersen PH, Miletic H, Hovland R, Mørk S, Bjerkvig R, Tiron C, McCormack E, Micklem D, Lorens JB, Immervoll H, Thorsen F. Novel brain metastases model developed in immunodeficient rats closely mimics the growth of metastatic brain tumours in patients. Neuropathol Appl Neurobiol 37:189-205, 2011.

Ke XS, Li WC, Hovland R, Qu Y, Liu RH, McCormack E, Thorsen F, Olsen JR, Molven A, Kogan-Sakin I, Rotter V, Akslen LA, Oyan AM, Kalland KH. Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model. Exp Cell Res 317:234-247, 2011.

Thorsen F. MRI of experimental gliomas. Methods Mol Biol 711:451-471, 2011.

Keunen O, Johansson M, Oudin A,Sanzey M, Abdul Rahim SA, Fack F, Thorsen F, Taxt T, Bartos M, Jirik R, Miletic H, Wang J, Stieber D, Stuhr L, Moen I, Rygh C, Bjerkvig R, Niclou SP. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. PNAS 108:3749-3754, 2011.

Skavland J, Jørgensen KM, Hadziavdic K, Hovland R, Jonassen I, Bruserud Ø and Gjertsen BT. Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia. Blood Cancer J 1(2):e4; 2011.

Olsnes C, Olofsson J, Aarstad HJ. Scand J. MAPKs ERK and p38, but not JNK phosphorylation, modulate IL-6 and TNF-a secretion following OK-432 in vitro stimulation of purified human monocytes. Immunol 74(2):114-25, 2011.

Svendsen A, Verhoeff JJ, Immervoll H, Brøgger JC, Kmiecik J, Poli A, Netland IA, Prestegarden L, Planagumà J, Torsvik A, Kjersem AB, Sakariassen PO, Heggdal JI, Van Furth WR, Bjerkvig R, Lund-Johansen M, Enger PO, Felsberg J, Brons NH, Tronstad KJ, Waha A, Chekenya M. Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma. Acta Neuropathol 122(4):495-510, 2011.

Leandro J, Saraste J, Leandro P, Flatmark T. The G46S-hPAH mutant protein: A model to study the rescue of aggregation-prone PKU mutations by chaperones. Mol Genet Metab 104 Suppl S40-4, 2011.

Johansson BB, Torsvik J, Gundersen L, Vesterhus M, Ragvin A, Tjora E, Fjeld K, Hoem D, Johansson S, Rader H, Lindquist S, Hernell O, Cnop M, Saraste J, Flatmark T, Molven A, Njolstad PR. Diabetes and pancreatic exocrine dysfunction due to mutations in the carboxyl-ester lipase gene (CEL-MODY): a protein misfolding disease. J Biol Chem 286(40):34593-605, 2011.

Wang J, Svendsen A, Kmiecik J, Immervoll H, Skaftnesmo KO, Planagumà J, Reed RK, Bjerkvig R, Miletic H, Enger PØ, Rygh CB, Chekenya M. Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma. PLoS One 6(7):e23062, 2011.

Hegen A, Blois A, Tiron CE, Hellesøy M, Micklem DR, Nör JE, Akslen LA, Lorens JB. Efficient in vivo vascularization of tissue-engineering scaffolds. J Tissue Eng Regen Med. 5(4):e52-62, 2011.

Furevik A, Pettersen EF, Colquhoun D, Wergeland HI. The intracellular lifestyle of Francisella noatunensis in Atlantic cod (Gadus morhua L.) leucocytes. Fish Shellfish Immunol 30(2):488-94, 2011.

Szyszko EA, Brokstad KA, Oijordsbakken G, Jonsson MV, Jonsson R, Skarstein K. Salivary glands of primary Sjögren's syndrome patients express factors vital for plasma cell survival. Arthritis Res Ther 13(1):R2, 2011.

Merrifield, D.L., Olsen, R.E., Myklebust, R. and Ringø, E. Dietary effect of soybean (Glycine max) products on gut histology and microbiota of fish. In: Soybean and Nutrition. El-Shemy, S (ed.). pp. 231-250. InTech - Open Access Publisher, ISBN 978-953-307-536-5, 2011.

Salma, W., Zhou, Z., Wang, W., Askarian, F., Kousha, A., Ebrahimi, M.T., Myklebust, R. and Ringø, E. Histological and bacteriological changes in intestine of beluga (Huso huso) following ex vivo exposure to bacterial strains. Aquaculture 314, 24-33, 2011.

Totland C, Aarskog NK, Eichler TW, Haugen M, Nøstbakken JK, Monstad SE, Salvesen HB, Mørk S, Haukanes BI, Vedeler CA. CDR2 antigen and Yo antibodies. Cancer Immunol Immunother 60(2):283-9, 2011.

Ardawatia VV, Masià-Balagué M, Krakstad BF, Johansson BB, Kreitzburg KM, Spriet E, Lewis AE, Meigs TE, Aragay AM. Gα(12) binds to the N-terminal regulatory domain of p120(ctn), and downregulates p120(ctn) tyrosine phosphorylation induced by Src family kinases via a RhoA independent mechanism. Exp Cell Res. 17(3):293-306, 2011.

Leandro J, Simonsen N, Saraste J, Leandro P, Flatmark T. Phenylketonuria as a protein misfolding disease: The mutation pG46S in phenylalanine hydroxylase promotes self-association and fibril formation. Biochim Biophys Acta 1812(1):106-120, 2011.